Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Advanced Oncotherapy's technology can slash costs of proton therapy cancer treatment says CEO

Advanced Oncotherapy's technology can slash costs of proton therapy cancer treatment says CEO

Proton therapy is a very precise but currently very expensive cancer treatment but Advanced Onco’s light technology eliminates the need for much of the previously necessary infrastructure, says Nicolas Serandour, the company's CEO.

Later this year, AVO will demonstrate equipment that can produce a beam of ionising radiation with a power of 230 MeV.

At that point, AVO will be able to treat any tumour regardless of depth, says Serandour, following which it will begin the necessary procedures for regulatory approval.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK